Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 167

1.

Pioneer and nonpioneer factor cooperation drives lineage specific chromatin opening.

Mayran A, Sochodolsky K, Khetchoumian K, Harris J, Gauthier Y, Bemmo A, Balsalobre A, Drouin J.

Nat Commun. 2019 Aug 23;10(1):3807. doi: 10.1038/s41467-019-11791-9.

2.

CDH1 and DDR1 common variants confer risk to vitiligo and autoimmune comorbidities.

Almasi-Nasrabadi M, Amoli MM, Robati RM, Rajabi F, Ghalamkarpour F, Gauthier Y.

Gene. 2019 Jun 5;700:17-22. doi: 10.1016/j.gene.2019.03.026. Epub 2019 Mar 16.

PMID:
30890477
3.

Evaluation of using fractional CO2 laser plus NB-UVB versus NB-UVB alone in inducing marginal repigmentation of vitiligo lesions.

Ghasemloo S, Gauthier Y, Ghalamkarpour F.

J Dermatolog Treat. 2019 Nov;30(7):697-700. doi: 10.1080/09546634.2018.1564232. Epub 2019 Jun 19.

PMID:
30592235
4.

Oestrogen associated with ultraviolet B irradiation recapitulates the specific melanosome distribution observed in caucasoid melasma.

Gauthier Y, Cario M, Pain C, Lepreux S, Benzekri L, Taieb A.

Br J Dermatol. 2019 Apr;180(4):951-953. doi: 10.1111/bjd.17453. Epub 2019 Jan 1. No abstract available.

PMID:
30478899
5.

Commissioning of the ECR ion source of the high intensity proton injector of the Facility for Antiproton and Ion Research (FAIR).

Tuske O, Chauvin N, Delferriere O, Fils J, Gauthier Y.

Rev Sci Instrum. 2018 May;89(5):052303. doi: 10.1063/1.5017783.

PMID:
29864844
6.

Regulatory integration of Hox factor activity with T-box factors in limb development.

Jain D, Nemec S, Luxey M, Gauthier Y, Bemmo A, Balsalobre A, Drouin J.

Development. 2018 Mar 22;145(6). pii: dev159830. doi: 10.1242/dev.159830.

7.

Pioneer factor Pax7 deploys a stable enhancer repertoire for specification of cell fate.

Mayran A, Khetchoumian K, Hariri F, Pastinen T, Gauthier Y, Balsalobre A, Drouin J.

Nat Genet. 2018 Feb;50(2):259-269. doi: 10.1038/s41588-017-0035-2. Epub 2018 Jan 22.

PMID:
29358650
8.

Epidermal melanocytes in segmental vitiligo show altered expression of E-cadherin, but not P-cadherin.

Grill C, Benzekri L, Rubod A, Aktary Z, Ezzedine K, Taïeb A, Gauthier Y, Larue L, Delmas V.

Br J Dermatol. 2018 May;178(5):1204-1206. doi: 10.1111/bjd.16352. Epub 2018 Mar 25. No abstract available.

PMID:
29341072
9.

Nanoparticle-Based Dressing: The Future of Wound Treatment?: (Trends in Biotechnology 35, 770-784, 2017).

Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C.

Trends Biotechnol. 2018 Jan;36(1):119. doi: 10.1016/j.tibtech.2017.08.007. Epub 2017 Sep 22. No abstract available.

PMID:
28947211
10.

Nanoparticle-Based Dressing: The Future of Wound Treatment?

Berthet M, Gauthier Y, Lacroix C, Verrier B, Monge C.

Trends Biotechnol. 2017 Aug;35(8):770-784. doi: 10.1016/j.tibtech.2017.05.005. Epub 2017 Jun 20. Review. Erratum in: Trends Biotechnol. 2018 Jan;36(1):119.

PMID:
28645529
11.

The first transepidermal transplantation of non-cultured epidermal suspension using a dermarolling system in vitiligo: A sequential histological and clinical study.

Benzekri L, Gauthier Y.

Pigment Cell Melanoma Res. 2017 Sep;30(5):493-497. doi: 10.1111/pcmr.12600. Epub 2017 Jul 4.

PMID:
28544808
12.

Loss-of-function mutations in the CABLES1 gene are a novel cause of Cushing's disease.

Hernández-Ramírez LC, Gam R, Valdés N, Lodish MB, Pankratz N, Balsalobre A, Gauthier Y, Faucz FR, Trivellin G, Chittiboina P, Lane J, Kay DM, Dimopoulos A, Gaillard S, Neou M, Bertherat J, Assié G, Villa C, Mills JL, Drouin J, Stratakis CA.

Endocr Relat Cancer. 2017 Aug;24(8):379-392. doi: 10.1530/ERC-17-0131. Epub 2017 May 22.

13.

Clinical markers of vitiligo activity.

Benzekri L, Gauthier Y.

J Am Acad Dermatol. 2017 May;76(5):856-862. doi: 10.1016/j.jaad.2016.12.040. Epub 2017 Feb 27.

PMID:
28245942
14.

Repigmentation in vitiligo: position paper of the Vitiligo Global Issues Consensus Conference.

Gan EY, Eleftheriadou V, Esmat S, Hamzavi I, Passeron T, Böhm M, Anbar T, Goh BK, Lan CE, Lui H, Ramam M, Raboobee N, Katayama I, Suzuki T, Parsad D, Seth V, Lim HW, van Geel N, Mulekar S, Harris J, Wittal R, Benzekri L, Gauthier Y, Kumarasinghe P, Thng ST, Silva de Castro CC, Abdallah M, Vrijman C, Bekkenk M, Seneschal J, Pandya AG, Ezzedine K, Picardo M, Taïeb A; VGICC.

Pigment Cell Melanoma Res. 2017 Jan;30(1):28-40. doi: 10.1111/pcmr.12561.

PMID:
27864868
15.

[Crossroads, 50 years of child care].

Gignac M, Boileau B, Bedwani CN, DiNicola V, Gauthier Y, Lévesque A, Morissette L.

Sante Ment Que. 2015 Summer;40(2):191-203. French.

PMID:
26559215
16.

Developing core outcome set for vitiligo clinical trials: international e-Delphi consensus.

Eleftheriadou V, Thomas K, van Geel N, Hamzavi I, Lim H, Suzuki T, Katayama I, Anbar T, Abdallah M, Benzekri L, Gauthier Y, Harris J, Silva de Castro CC, Pandya A, Goh BK, Lan CC, Oiso N, Al Issa A, Esmat S, Le Poole C, Lee AY, Parsad D, Taieb A, Picardo M, Ezzedine K; Vitiligo Global Issues Consensus Group.

Pigment Cell Melanoma Res. 2015 May;28(3):363-9. doi: 10.1111/pcmr.12354. Epub 2015 Feb 13. No abstract available.

PMID:
25645179
17.

Altered E-Cadherin Levels and Distribution in Melanocytes Precede Clinical Manifestations of Vitiligo.

Wagner RY, Luciani F, Cario-André M, Rubod A, Petit V, Benzekri L, Ezzedine K, Lepreux S, Steingrimsson E, Taieb A, Gauthier Y, Larue L, Delmas V.

J Invest Dermatol. 2015 Jul;135(7):1810-1819. doi: 10.1038/jid.2015.25. Epub 2015 Jan 29.

18.

Hypochromic vitiligo: delineation of a new entity.

Ezzedine K, Mahé A, van Geel N, Cardot-Leccia N, Gauthier Y, Descamps V, Al Issa A, Ly F, Chosidow O, Taïeb A, Passeron T.

Br J Dermatol. 2015 Mar;172(3):716-21. doi: 10.1111/bjd.13423. Epub 2014 Dec 11.

PMID:
25255745
19.

Possible patterns of epidermal melanocyte disappearance in nonsegmental vitiligo: a clinicopathological study.

Benzekri L, Hmamouchi I, Gauthier Y.

Br J Dermatol. 2015 Feb;172(2):331-6. doi: 10.1111/bjd.13160. Epub 2014 Nov 12.

PMID:
24902987
20.

Whose Rights Count? Negotiating Practice, Policy, and Legal Dilemmas Regarding Infant-Parent Contact When Infants are in Out-of-Home Care.

Miron D, Bisaillon C, Jordan B, Bryce G, Gauthier Y, St-Andre M, Minnis H.

Infant Ment Health J. 2013 Mar;34(2):177-188.

21.

[Brunschvicg, bachelard and the internal logic of scientific discourse].

Gauthier Y.

Rev Synth. 2013;134(3):343-53. doi: 10.1007/s11873-013-0225-8. French.

PMID:
24091652
22.

Possible mechanisms by which topical 5-Fluorouracil and dermabrasion could induce pigment spread in vitiligo skin: an experimental study.

Gauthier Y, Anbar T, Lepreux S, Cario-André M, Benzekri L.

ISRN Dermatol. 2013 Apr 9;2013:852497. doi: 10.1155/2013/852497. Print 2013.

23.

Vitiligo Potential Repigmentation Index: a simple clinical score that might predict the ability of vitiligo lesions to repigment under therapy.

Benzekri L, Ezzedine K, Gauthier Y.

Br J Dermatol. 2013 May;168(5):1143-6. doi: 10.1111/bjd.12147. Epub 2013 Mar 7. No abstract available.

PMID:
23464539
24.

DISCRIMINATION OF Burkholderia mallei/pseudomallei FROM Burkholderia thailandensis BY SEQUENCE COMPARISON OF A FRAGMENT OF THE RIBOSOMAL PROTEIN S21 (RPSU) GENE.

Frickmann H, Chantratita N, Gauthier YP, Neubauer H, Hagen RM.

Eur J Microbiol Immunol (Bp). 2012 Jun 13;2(2):148-156.

25.

The selector gene Pax7 dictates alternate pituitary cell fates through its pioneer action on chromatin remodeling.

Budry L, Balsalobre A, Gauthier Y, Khetchoumian K, L'honoré A, Vallette S, Brue T, Figarella-Branger D, Meij B, Drouin J.

Genes Dev. 2012 Oct 15;26(20):2299-310. doi: 10.1101/gad.200436.112.

26.

Clinical features and histological findings are potential indicators of activity in lesions of common vitiligo.

Benzekri L, Gauthier Y, Hamada S, Hassam B.

Br J Dermatol. 2013 Feb;168(2):265-71. doi: 10.1111/bjd.12034. Epub 2012 Dec 13.

PMID:
22963656
27.

Guidelines for the management of vitiligo: the European Dermatology Forum consensus.

Taieb A, Alomar A, Böhm M, Dell'anna ML, De Pase A, Eleftheriadou V, Ezzedine K, Gauthier Y, Gawkrodger DJ, Jouary T, Leone G, Moretti S, Nieuweboer-Krobotova L, Olsson MJ, Parsad D, Passeron T, Tanew A, van der Veen W, van Geel N, Whitton M, Wolkerstorfer A, Picardo M; Vitiligo European Task Force (VETF); European Academy of Dermatology and Venereology (EADV); Union Europe´enne des Me´decins Spe´cialistes (UEMS).

Br J Dermatol. 2013 Jan;168(1):5-19. doi: 10.1111/j.1365-2133.2012.11197.x. Epub 2012 Nov 2.

PMID:
22860621
28.

Revised classification/nomenclature of vitiligo and related issues: the Vitiligo Global Issues Consensus Conference.

Ezzedine K, Lim HW, Suzuki T, Katayama I, Hamzavi I, Lan CC, Goh BK, Anbar T, Silva de Castro C, Lee AY, Parsad D, van Geel N, Le Poole IC, Oiso N, Benzekri L, Spritz R, Gauthier Y, Hann SK, Picardo M, Taieb A; Vitiligo Global Issue Consensus Conference Panelists.

Pigment Cell Melanoma Res. 2012 May;25(3):E1-13. doi: 10.1111/j.1755-148X.2012.00997.x.

29.

Preliminary results of the International Fusion Materials Irradiation Facility deuteron injector.

Gobin R, Adroit G, Bogard D, Bourdelle G, Chauvin N, Delferrière O, Gauthier Y, Girardot P, Guiho P, Harrault F, Jannin JL, Loiseau D, Mattei P, Roger A, Sauce Y, Senée F, Vacher T.

Rev Sci Instrum. 2012 Feb;83(2):02A345. doi: 10.1063/1.3673643.

PMID:
22380192
30.

Light ion source for proton∕deuteron production at CEA Saclay for the Spiral2 project.

Tuske O, Adroit G, Delferrière O, Denis JF, Gauthier Y, Girardot P, Gobin R, Harrault F, Graehling P, Guiho P, Hosselet J, Maazouzi C, Sauce Y, Uriot D, Vacher T, Van Hille C.

Rev Sci Instrum. 2012 Feb;83(2):02A316. doi: 10.1063/1.3665963.

PMID:
22380163
31.

Non-cultured epidermal suspension in vitiligo: from laboratory to clinic.

Gauthier Y, Benzekri L.

Indian J Dermatol Venereol Leprol. 2012 Jan-Feb;78(1):59-63. doi: 10.4103/0378-6323.90947.

32.

Opening remarks.

Tuters E, Gauthier Y.

Infant Ment Health J. 2011 Nov;32(6):582. doi: 10.1002/imhj.20316. Epub 2011 Oct 18. No abstract available.

PMID:
28520161
33.

Child analysis in a changing world. In the face of a paradigm shift from the mind to the brain: Can we meet the challenge?

Gauthier Y.

Infant Ment Health J. 2011 Nov;32(6):583-595. doi: 10.1002/imhj.20317.

PMID:
28520157
34.
35.

Halo naevi and leukotrichia are strong predictors of the passage to mixed vitiligo in a subgroup of segmental vitiligo.

Ezzedine K, Diallo A, Léauté-Labrèze C, Séneschal J, Prey S, Ballanger F, Alghamdi K, Cario-André M, Jouary T, Gauthier Y, Taieb A.

Br J Dermatol. 2012 Mar;166(3):539-44. doi: 10.1111/j.1365-2133.2011.10709.x.

PMID:
22032627
36.

Differential role of the interleukin-17 axis and neutrophils in resolution of inhalational anthrax.

Garraud K, Cleret A, Mathieu J, Fiole D, Gauthier Y, Quesnel-Hellmann A, Tournier JN.

Infect Immun. 2012 Jan;80(1):131-42. doi: 10.1128/IAI.05988-11. Epub 2011 Oct 24.

37.

Rapid identification of Burkholderia pseudomallei and Burkholderia mallei by fluorescence in situ hybridization (FISH) from culture and paraffin-embedded tissue samples.

Hagen RM, Frickmann H, Elschner M, Melzer F, Neubauer H, Gauthier YP, Racz P, Poppert S.

Int J Med Microbiol. 2011 Nov;301(7):585-90. doi: 10.1016/j.ijmm.2011.04.017. Epub 2011 Jun 11.

PMID:
21658996
38.

Segmental vitiligo associated with generalized vitiligo (mixed vitiligo): a retrospective case series of 19 patients.

Ezzedine K, Gauthier Y, Léauté-Labrèze C, Marquez S, Bouchtnei S, Jouary T, Taieb A.

J Am Acad Dermatol. 2011 Nov;65(5):965-71. doi: 10.1016/j.jaad.2010.08.031. Epub 2011 May 25.

PMID:
21616559
39.

Multivariate analysis of factors associated with early-onset segmental and nonsegmental vitiligo: a prospective observational study of 213 patients.

Ezzedine K, Diallo A, Léauté-Labrèze C, Mossalayi D, Gauthier Y, Bouchtnei S, Cario-André M, Seneschal J, Boralevi F, Jouary T, Taieb A.

Br J Dermatol. 2011 Jul;165(1):44-9. doi: 10.1111/j.1365-2133.2011.10311.x. Epub 2011 Jun 2.

PMID:
21410675
40.

Koebner's phenomenon in vitiligo: European position paper.

van Geel N, Speeckaert R, Taieb A, Picardo M, Böhm M, Gawkrodger DJ, Schallreuter K, Bennett DC, van der Veen W, Whitton M, Moretti S, Westerhof W, Ezzedine K, Gauthier Y; VETF members.

Pigment Cell Melanoma Res. 2011 Jun;24(3):564-73. doi: 10.1111/j.1755-148X.2011.00838.x. Epub 2011 Mar 7. Review.

PMID:
21324101
41.

Different phenotypes of segmental vitiligo based on a clinical observational study.

van Geel N, De Lille S, Vandenhaute S, Gauthier Y, Mollet I, Brochez L, Lambert J.

J Eur Acad Dermatol Venereol. 2011 Jun;25(6):673-8. doi: 10.1111/j.1468-3083.2010.03847.x. Epub 2010 Sep 14.

PMID:
20840343
42.

Interview with Yvon Gauthier MD. Interviewed by Normand Carrey MD.

Gauthier Y.

J Can Acad Child Adolesc Psychiatry. 2009 May;18(2):139-43. No abstract available.

43.

Commentary to When attachment disorder presents with symptoms of gender identity disorder: case discussion.

Gauthier Y.

J Can Acad Child Adolesc Psychiatry. 2009 May;18(2):138. No abstract available.

44.

Efficacy of a vaccine based on protective antigen and killed spores against experimental inhalational anthrax.

Gauthier YP, Tournier JN, Paucod JC, Corre JP, Mock M, Goossens PL, Vidal DR.

Infect Immun. 2009 Mar;77(3):1197-207. doi: 10.1128/IAI.01217-08. Epub 2008 Dec 29.

45.

Segmental vitiligo as the possible expression of cutaneous somatic mosaicism: implications for common non-segmental vitiligo.

Taïeb A, Morice-Picard F, Jouary T, Ezzedine K, Cario-André M, Gauthier Y.

Pigment Cell Melanoma Res. 2008 Dec;21(6):646-52. doi: 10.1111/j.1755-148X.2008.00511.x. Epub 2008 Oct 28. Review.

PMID:
18983534
46.

[Is child's well-being the presumption of the Tribunal in favor of child custody?].

Gauthier Y.

Sante Ment Que. 2008 Spring;33(1):203-8. French. No abstract available.

PMID:
18795203
47.

Burkholderia pseudomallei aerosol infection results in differential inflammatory responses in BALB/c and C57Bl/6 mice.

Tan GY, Liu Y, Sivalingam SP, Sim SH, Wang D, Paucod JC, Gauthier Y, Ooi EE.

J Med Microbiol. 2008 Apr;57(Pt 4):508-15. doi: 10.1099/jmm.0.47596-0.

PMID:
18349373
48.

BETSI, a new test bench for ion sources optimization at CEA SACLAY.

Tuske O, Adroit G, Delferrière O, De Menezes D, Gauthier Y, Gobin R, Harrault F.

Rev Sci Instrum. 2008 Feb;79(2 Pt 2):02B710. doi: 10.1063/1.2805625.

PMID:
18315201
49.

A 140 mA cw deuteron electron cyclotron resonance source for the IFMIF-EVEDA project.

Gobin R, Beauvais PY, Delferrière O, De Menezes D, Tuske O, Adroit G, Gauthier Y, Harrault F.

Rev Sci Instrum. 2008 Feb;79(2 Pt 2):02B303. doi: 10.1063/1.2801976.

PMID:
18315169
50.

Pseudomonas aeruginosa virulence genes identified in a Dictyostelium host model.

Alibaud L, Köhler T, Coudray A, Prigent-Combaret C, Bergeret E, Perrin J, Benghezal M, Reimmann C, Gauthier Y, van Delden C, Attree I, Fauvarque MO, Cosson P.

Cell Microbiol. 2008 Mar;10(3):729-40. Epub 2007 Nov 27.

PMID:
18042255

Supplemental Content

Loading ...
Support Center